Cytomegalovirus infection screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(7 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
All donors and transplant candidates should be tested for [[Cytomegalovirus infection|CMV]] [[serology]] prior to [[transplantation]] in order to allow for risk stratification and guide prevention strategies.


==Screening==
==Screening==
There is no standard screening recommended for cytomegalovirus infection due to the high seroprevalence.
All donors and transplant candidates should be tested for [[Cytomegalovirus infection|CMV]] serology prior to [[transplantation]] in order to allow for risk stratification and guide prevention strategies.
 
==References==
{{Reflist|2}}
 
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Neurosurgery]]
[[Category:Gastroenterology]]
[[Category:Ophthalmology]]

Latest revision as of 21:13, 29 July 2020

Cytomegalovirus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cytomegalovirus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cytomegalovirus infection screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cytomegalovirus infection screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cytomegalovirus infection screening

CDC on Cytomegalovirus infection screening

Cytomegalovirus infection screening in the news

Blogs on Cytomegalovirus infection screening

Directions to Hospitals Treating Cytomegalovirus infection

Risk calculators and risk factors for Cytomegalovirus infection screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.

Screening

All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.

References